• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Technology·MLOCT.PA
Share

Octopus Biosafety SA Stocks

€ 0.19Last Updated 05.06.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

€ 27.54M

€ 0.19
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MCAI SAS designs, develops, manufactures, and market mobile and autonomous robots intended to decontaminate facilities, such as airports, industrial buildings, and public buildings. Its products are also used to aerosolize phytosanitary products and other substances; to atomize liquid substances, such as biocides, phytosanitary solutions, and pesticides; and carry specific modules and equipment, such as detection/monitoring systems, unmanned aircraft systems/drones, etc. The company also provides Octopus Poultry Safe, a robot that assists breeders in monitoring their routine, mapping indoor temperature and relative humidity, CO2/ammonia and sound/brightness levels, and other parameters; and Octopus Biosafety, which provides civil defense/civil protection professionals with a means of microbial contamination prevention and control in case of a pandemic or bioterrorism attack. It offers its products for agro-food, animal healthcare, biotech, security, transport, and defense industries. The company was founded in 1987 and is based in Cholet, France.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.06.2026 16:00

Morning in New York: news contributes to moderate positivity

09.06.2026 15:46

'Downgrade Game' investor names a stock to hold for a lifetime

09.06.2026 15:00

WhiteHawk IPO: Shares of a company that makes money from gas production begin trading

09.06.2026 14:08

European small-caps are outperforming the market. What strategy does BNP Paribas AM advise?

09.06.2026 12:45

Button for investors: what will change for Kazakhstan's accession to Euroclear

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026